CUPERTINO, Calif.--(BUSINESS WIRE)--NextBio (www.nextbio.com) announced today that Dr. B. Michael Silber, former Senior Vice President and Site Head of Preclinical R&D (Safety & Technical Sciences) at Roche Pharmaceuticals, has joined the company’s Scientific Advisory Board. “Dr. Silber has been a major figure in the pharmaceutical industry for more than twenty years. His leadership has been essential in the successful development of a variety of innovative new medicines that are widely used in the world today,” stated NextBio co-founder and CEO Saeid Akhtari. “We are honored that Michael Silber has joined the NextBio team. His experience and commitment to scientific excellence will be vital as we move forward.”
